Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy
Angeliki Tiptiri-Kourpeti, Katerina Spyridopoulou, Aglaia Pappa, et al.
Pharmacology & Therapeutics (2016) Vol. 165, pp. 32-49
Closed Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Jian Liu, Minyang Fu, Manni Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 481
DNA Vaccines—How Far From Clinical Use?
Dominika Hobernik, Matthias Bros
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 11, pp. 3605-3605
Open Access | Times Cited: 427
Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
Alessandra Lopes, Gaëlle Vandermeulen, Véronique Préat
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 332
Biomaterials for vaccine-based cancer immunotherapy
Rui Zhang, Margaret M. Billingsley, Michael J. Mitchell
Journal of Controlled Release (2018) Vol. 292, pp. 256-276
Open Access | Times Cited: 173
Cancer Vaccines, Adjuvants, and Delivery Systems
Samantha Paston, Victoria A. Brentville, Peter Symonds, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 145
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Qing Li, Shan Geng, Hao Luo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 47
Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy
Popat Mohite, Vaishnavi Yadav, Ramdas Pandhare, et al.
ACS Omega (2024)
Open Access | Times Cited: 19
Development of nucleic acid-based vaccines against dengue and other mosquito-borne flaviviruses: the past, present, and future
Muhammad Bashir Bello, Ahlam Alsaadi, Asif Naeem, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 2
Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy
Alvin J. Mukalel, Rachel Riley, Rui Zhang, et al.
Cancer Letters (2019) Vol. 458, pp. 102-112
Open Access | Times Cited: 103
Therapeutic cancer vaccines: From initial findings to prospects
Qian Song, Cheng-dong Zhang, Xianghua Wu
Immunology Letters (2018) Vol. 196, pp. 11-21
Closed Access | Times Cited: 93
The interactions of paclitaxel with tumour microenvironment
Ding‐Li Yu, Zhiping Lou, Fengyun Ma, et al.
International Immunopharmacology (2022) Vol. 105, pp. 108555-108555
Closed Access | Times Cited: 67
Hydrogel-guided strategies to stimulate an effective immune response for vaccine-based cancer immunotherapy
Lei Lei, Dennis Huang, Huile Gao, et al.
Science Advances (2022) Vol. 8, Iss. 47
Open Access | Times Cited: 64
Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects
Madhu Gupta, Abhishek Wahi, Priyanka Sharma, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2011-2011
Open Access | Times Cited: 48
Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects
Zahid Rafiq, M.J. Kang, Hampartsoum B. Barsoumian, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications
Ishita Gupta, Ola Hussein, Konduru S. Sastry, et al.
Advances in Cancer Biology - Metastasis (2023) Vol. 8, pp. 100107-100107
Open Access | Times Cited: 19
Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies
Yuanyuan Guo, Fengyuan Gao, Adeel Ahmed, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 36, pp. 8586-8604
Closed Access | Times Cited: 19
Lipid-based colloidal nanoparticles for applications in targeted vaccine delivery
Muhammad Saad Khan, Sila Appak Baskoy, Celina Yang, et al.
Nanoscale Advances (2023) Vol. 5, Iss. 7, pp. 1853-1869
Open Access | Times Cited: 17
Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy
Salima Shebbo, Najat Binothman, Manar Darwaish, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy
Komal Kumari, Amarnath Singh, Archana Chaudhary, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 498-498
Open Access | Times Cited: 7
Next-generation cancer vaccines and emerging immunotherapy combinations
Anne Brandenburg, Annkristin Heine, Peter Brossart
Trends in cancer (2024) Vol. 10, Iss. 8, pp. 749-769
Closed Access | Times Cited: 6
Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapy
Zohreh Jahanafrooz, Fatemeh Oroojalian, Ahad Mokhtarzadeh, et al.
Drug Development Research (2024) Vol. 85, Iss. 5
Closed Access | Times Cited: 6
Synthetic multiepitope neoantigen DNA vaccine for personalized cancer immunotherapy
Xiaoyue Yang, Jiansheng Fan, Yue Wu, et al.
Nanomedicine Nanotechnology Biology and Medicine (2021) Vol. 37, pp. 102443-102443
Closed Access | Times Cited: 36
Overcoming Suppressive Tumor Microenvironment by Vaccines in Solid Tumor
Ya‐Jia Xie, Wen-Qian Liu, Dan Li, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 394-394
Open Access | Times Cited: 14
Recent advancements in cancer vaccines: A systematic review
Stuti Srivastava, Devendra Singh, Sunil Kumar Verma, et al.
Vacunas (English Edition) (2024) Vol. 25, Iss. 1, pp. 97-108
Closed Access | Times Cited: 5
Advancements in Melanoma Therapies: From Surgery to Immunotherapy
Neda Shajari, Behzad Baradaran, Mohammad Reza Tohidkia, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 8, pp. 1073-1088
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top